Loading...
6033

Guangxi LiuYao Group Co., LtdSHSE:603368 Stock Report

Market Cap CN¥7.2b
Share Price
CN¥18.17
My Fair Value
CN¥23
20.0% undervalued intrinsic discount
1Y14.5%
7D-2.5%
Portfolio Value
View

Guangxi LiuYao Group Co., Ltd

SHSE:603368 Stock Report

Market Cap: CN¥7.2b

Guangxi LiuYao Group (603368) Stock Overview

Engages in the wholesale and retail of pharmaceutical products in China. More details

603368 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends6/6

603368 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Guangxi LiuYao Group Co., Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Guangxi LiuYao Group
Historical stock prices
Current Share PriceCN¥18.17
52 Week HighCN¥20.99
52 Week LowCN¥14.53
Beta0.36
1 Month Change-0.93%
3 Month Change8.22%
1 Year Change14.49%
3 Year Change10.25%
5 Year Change-28.01%
Change since IPO22.61%

Recent News & Updates

Recent updates

Guangxi LiuYao Group's (SHSE:603368) Promising Earnings May Rest On Soft Foundations

Nov 05
Guangxi LiuYao Group's (SHSE:603368) Promising Earnings May Rest On Soft Foundations

Returns On Capital Signal Tricky Times Ahead For Guangxi LiuYao Group (SHSE:603368)

Oct 28
Returns On Capital Signal Tricky Times Ahead For Guangxi LiuYao Group (SHSE:603368)

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Intrinsic Value Is Potentially 22% Below Its Share Price

Aug 07
Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Intrinsic Value Is Potentially 22% Below Its Share Price

Guangxi LiuYao Group (SHSE:603368) Is Increasing Its Dividend To CN¥0.60

Jun 06
Guangxi LiuYao Group (SHSE:603368) Is Increasing Its Dividend To CN¥0.60

Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

May 21
Guangxi LiuYao Group (SHSE:603368) Has A Pretty Healthy Balance Sheet

Guangxi LiuYao Group's (SHSE:603368) Earnings Are Weaker Than They Seem

May 02
Guangxi LiuYao Group's (SHSE:603368) Earnings Are Weaker Than They Seem

A Look At The Fair Value Of Guangxi LiuYao Group Co., Ltd (SHSE:603368)

Apr 18
A Look At The Fair Value Of Guangxi LiuYao Group Co., Ltd (SHSE:603368)

Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Mar 04
Guangxi LiuYao Group Co., Ltd's (SHSE:603368) Price Is Right But Growth Is Lacking After Shares Rocket 26%

Shareholder Returns

603368CN HealthcareCN Market
7D-2.5%-1.5%1.8%
1Y14.5%27.7%48.6%

Return vs Industry: 603368 underperformed the CN Healthcare industry which returned 28.6% over the past year.

Return vs Market: 603368 underperformed the CN Market which returned 50.6% over the past year.

Price Volatility

Is 603368's price volatile compared to industry and market?
603368 volatility
603368 Average Weekly Movement2.0%
Healthcare Industry Average Movement3.4%
Market Average Movement5.0%
10% most volatile stocks in CN Market8.6%
10% least volatile stocks in CN Market2.9%

Stable Share Price: 603368 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 603368's weekly volatility (2%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19815,513Chaoyang Zhuweb.lzyy.cn

Guangxi LiuYao Group Co., Ltd engages in the wholesale and retail of pharmaceutical products in China. It also offers smart medicine value-added services. The company was founded in 1981 and is based in Liuzhou, China.

Guangxi LiuYao Group Co., Ltd Fundamentals Summary

How do Guangxi LiuYao Group's earnings and revenue compare to its market cap?
603368 fundamental statistics
Market capCN¥7.21b
Earnings (TTM)CN¥831.86m
Revenue (TTM)CN¥20.72b
8.7x
P/E Ratio
0.3x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
603368 income statement (TTM)
RevenueCN¥20.72b
Cost of RevenueCN¥18.41b
Gross ProfitCN¥2.31b
Other ExpensesCN¥1.48b
EarningsCN¥831.86m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)2.10
Gross Margin11.17%
Net Profit Margin4.01%
Debt/Equity Ratio53.7%

How did 603368 perform over the long term?

See historical performance and comparison

Dividends

4.1%
Current Dividend Yield
36%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/08/29 18:42
End of Day Share Price 2025/08/29 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guangxi LiuYao Group Co., Ltd is covered by 9 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Diandian LiChina Merchants Securities Co. Ltd.
Wai Ming KongDBS Bank Ltd
Wai Ming KongDBS Vickers Research